RN

Rama Krishna Narla

PI Parker Hughes Institute: 12 patents #4 of 40Top 10%
SP Signal Pharmaceuticals: 11 patents #29 of 207Top 15%
BS Bristol-Myers Squibb: 11 patents #481 of 3,969Top 15%
UM University of Minnesota: 1 patents #1,216 of 2,951Top 45%
📍 San Diego, CA: #1,090 of 23,606 inventorsTop 5%
🗺 California: #14,433 of 386,348 inventorsTop 4%
Overall (All Time): #101,342 of 4,157,543Top 3%
34
Patents All Time

Issued Patents All Time

Showing 1–25 of 34 patents

Patent #TitleCo-InventorsDate
12404241 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Massimo Ammirante, Sogole Bahmanyar, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +11 more 2025-09-02
12396995 Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use Maria Soraya Carrancio Anton, Tonia J. Buchholz, Henry Chang, Ellen Filvaroff, Shailaja Kasibhatla +5 more 2025-08-26
12178822 Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion Maria Soraya Carrancio Anton, Tonia J. Buchholz, Shailaja Kasibhatla, Antonia Lopez-Girona, Michael Pourdehnad 2024-12-31
12103923 Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione Maria Soraya Carrancio Anton, Tonia J. Buchholz, Antonia Lopez-Girona, Michael Pourdehnad 2024-10-01
12029738 Antiproliferative compounds and methods of use thereof Matthew D. Alexander, Gerald D. Artman, III, Gordon L. Bray, James Carmichael, Soraya Carrancio +15 more 2024-07-09
11873283 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Massimo Ammirante, Sogole Bahmanyar, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +11 more 2024-01-16
11666579 Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione Maria Soraya Carrancio Anton, Tonia J. Buchholz, Shailaja Kasibhatla, Antonia Lopez-Girona, Michael Pourdehnad 2023-06-06
11583536 Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use Maria Soraya Carrancio Anton, Tonia J. Buchholz, Henry Chang, Ellen Filvaroff, Shailaja Kasibhatla +5 more 2023-02-21
11390617 Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione Maria Soraya Carrancio Anton, Tonia J. Buchholz, Antonia Lopez-Girona, Michael Pourdehnad 2022-07-19
11325889 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Massimo Ammirante, Sogole Bahmanyar, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +11 more 2022-05-10
11166950 Treatment of cancer with TOR kinase inhibitors Shuichan Xu, Kristen Mae Hege, Heather Raymon, Rajesh Chopra 2021-11-09
11149007 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Massimo Ammirante, Sogole Bahmanyar, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +11 more 2021-10-19
10391092 Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy Heather Raymon, Toshiya Tsuji, Kristen Mae Hege 2019-08-27
9937170 Treatment of cancer with TOR kinase inhibitors Shuichan Xu, Kristen Mae Hege, Antonia Lopez-Girona, Heather Raymon, Rajesh Chopra 2018-04-10
9937169 Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy Heather Raymon, Toshiya Tsuji, Kristen Mae Hege 2018-04-10
9795607 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more 2017-10-24
9493466 Treatment of cancer with TOR kinase inhibitors Shuichan Xu, Kristen Mae Hege, Antonia Lopez-Girona, Heather Raymon, Rajesh Chopra 2016-11-15
9428509 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more 2016-08-30
9346812 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more 2016-05-24
8507492 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-08-13
8492381 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-07-23
8110578 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2012-02-07
7038049 Haloanilino quinazolines and therapeutic use thereof Fatih M. Uckun, Xing-Ping Liu 2006-05-02
6878388 Vanadium compounds for treating proliferative cell disorders Fatih M. Uckun 2005-04-12
6797721 Phorboxazole derivatives for treating cancer Fatih M. Uckun, Craig J. Forsyth, Chi Lee, Feryan Ahmed, Russell D. Cink 2004-09-28